37 results
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
, and the expression “Prospectus Regulation” means Regulation (EU) 2017/1129.
MiFID II Product Governance
Any person offering, selling
424B5
h3vhjxz37th736bu
27 Sep 23
Prospectus supplement for primary offering
5:26pm
424B5
f9r8ifzrln
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
8o3wrv03kh4hpuha
23 Jun 20
Prospectus supplement for primary offering
4:06pm
8-K
6u8l0kxf zuw
29 Apr 19
Soleno Therapeutics Announces Appointment of Industry Veteran Gwen A. Melincoff to Board of Directors
4:03pm